"Molecular Pharmacognosy" discusses the application of molecular biology in resource science and authentication of traditional Chinese medicine (TCM). This book reviews the latest developments in pharmacognosy, introduces a series of new views and insights, presents the hotspots and focus of the field of study on molecular pharmacognosy, and predicts a new direction of study on the resource science of TCM. Furthermore, the book also provides an open communications platform for the development of molecular pharmacognosy. This book is intended for biomedical scientists and researchers in the fields of molecular biology, traditional medicine and natural pharmaceutics.

Professor Lu-qi Huang is Director of the Collaborating Centre of the World Health Organization for Traditional Medicine (Chinese Materia Medica) and Vice-Chairman of the Australia Chinese Association for Biomedical Sciences Inc.

Traditional Chinese Medicine has played an important role in the treatment of COVID-19 in China. As the first batch of national Chinese medicine team in China, the authors shared their experience of treating severe COVID-19 cases with TCM at Jinyintan Hospital in Wuhan, the epicenter of the outbreak in China. Twenty severe cases have been selected and reported in this book. The medical history, inspection results and treatment rationales have been described in detail, adequately illustrated with color pictures of the tongues.The book is organized as follows: The etiology and pathogenesis from TCM perspectives are comprehensively discussed in the introduction. Part I includes various theories of different experts. Part II presents reports of the clinical cases one by one.